The maker of pain medicine Lyrica and the blockbuster Prevnar 13 vaccine against pneumococcal infections said Tuesday that net income was $3.56 billion, or 59 cents per share. (NYSE:PFE). Private Trust Na owns 136,373 shs or 1.05% of their U.S. capital. Garland Management Inc holds 3.76% or 157,984 shares. The stock has a market capitalization of $217,934.38, a price-to-earnings ratio of 13.17, a PEG ratio of 1.83 and a beta of 0.89. EMCOR Group, Inc. (NYSE:EME) has risen 23.19% since May 2, 2017 and is uptrending. It has outperformed by 1.89% the S&P500. The drug company still expects revenues between $53.5 and $55.5 billion for the year, with earnings between $2.90 and $3.00 per share. Beacon Advsr reported 5,386 shares. Highvista Strategies Ltd Liability has invested 0.1% in Pfizer Inc.
Pfizer stock retreated 73 cents, or 2%, to $35.87, within a 52-week trading range of $31.67 to $39.43. That was up from $3.12 billion, or 51 cents per share, a year earlier, when there were more shares being publicly traded. It has underperformed by 9.12% the S&P500. That's change of 0.10, from 2017Q3's 0.96.
Nelson Roberts Investment Advisors LLC raised its holdings in shares of Pfizer (NYSE:PFE) by 98.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. Manchester Limited Liability Com owns 29,821 shares.
Pfizer Inc discovers, develops, manufactures, and sells healthcare products worldwide. (NYSE:PFE) was sold by LUND-JURGENSEN KIRSTEN. (NYSE:PFE). Davenport & Ltd Liability holds 255,613 shares or 0.11% of its portfolio. (NYSE:PFE) or 61,788 shares. Gilman Hill Asset Management Lc reported 133,790 shares. Marshwinds Advisory owns 123,352 shares. Everence Capital reported 0.12% in Marathon Petroleum Corporation (NYSE:MPC). The institutional investor held 309,906 shares of the health care company at the end of 2017Q4, valued at $11.23M, down from 334,332 at the end of the previous reported quarter. (NYSE:PFE). Moreover, Eagle Ridge Invest Management has 0.11% invested in Pfizer Inc. Family Mgmt Corporation invested in 0.35% or 13,687 shares. Following the completion of the transaction, the insider now directly owns 36,959 shares in the company, valued at $1,374,505.21. 21,600 are owned by Crestpoint Mgmt Ltd. Wilbanks Smith & Thomas Asset Mgmt Llc has invested 0.42% in Pfizer Inc. (NYSE:PFE) has "Buy" rating given on Thursday, July 14 by Jefferies. 563,457 were accumulated by Bokf Na. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has "Neutral" rating given on Wednesday, January 31 by Credit Suisse. The stock rating was maintained by Jefferies with "Hold" on Monday, February 26.
The stock of TDH Holdings, Inc.
Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. The rating was maintained by Jefferies on Tuesday, June 14 with "Buy". Suntrust Robinson upgraded it to "Neutral" rating and $37 target in Wednesday, November 25 report. (NYSE:PFE) has "Hold" rating given on Wednesday, August 16 by Jefferies. Finally, Vetr cut Pfizer from a "buy" rating to a "hold" rating and set a $37.98 price objective on the stock.in a research report on Monday, January 15th. The rating was downgraded by Barclays Capital to "Equal-Weight" on Thursday, April 5. The stock presently has an average rating of Hold and a consensus price target of $39.57.
Since December 15, 2017, it had 0 insider buys, and 12 insider sales for $12.99 million activity. Americafirst Capital Management LLC bought a new position in shares of Pfizer in the third quarter worth $127,000. (NYSE:PFE) shares were sold by LANKLER DOUGLAS M. 6,750 shares were sold by MACKENZIE ALEXANDER R, worth $249,750. $488,016 worth of stock was sold by BERG CHARLES on Monday, December 11. SUSMAN SALLY sold $1.24 million worth of Pfizer Inc. (NYSE:PFE) rating on Monday, February 26. Mckinley Capital Management LLC Delaware bought a new position in shares of Pfizer during the second quarter worth about $103,000.
Analysts await Safe Bulkers, Inc. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. equities analysts anticipate that Pfizer will post 2.96 EPS for the current fiscal year. SB's profit will be $2.03M for 38.38 P/E if the $0.02 EPS becomes a reality. (NYSE:PFE) has posted first-quarter sales that missed analyst estimates due in part to the loss last December of exclusivity of Viagra in the US and sales of its breast cancer drug Ibrance and arthritis drug Xeljanz that were below market expectations.
Since December 7, 2017, it had 0 insider purchases, and 6 insider sales for $8.31 million activity. The insider Dolsten Mikael sold $2.55 million.